Company Filing History:
Years Active: 1995-1997
Title: The Innovative Contributions of Anna Cuzzoni
Introduction
Anna Cuzzoni is a notable inventor based in Pavia, Italy. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant vectors for antibody production. With a total of three patents to her name, Cuzzoni's work has the potential to impact vaccine development and therapeutic applications.
Latest Patents
Cuzzoni's latest patents include a recombinant vector designed for the expression and secretion of antibodies in single molecule form (scFv) from Bacillus subtilis. This innovative vector incorporates the promoter of the gene for neutral protease, a new secretion sequence, and a DNA sequence coding for a scFv antibody of interest. The recombinant vector allows for the expression of scFv in a completely soluble form and its secretion in high yields. Another significant patent involves the cloning of the gene coding for the pilinic subunit fim3 of Bordetella pertussis. This cloned DNA fragment is particularly useful for developing acellular anti-pertussis vaccines.
Career Highlights
Throughout her career, Anna Cuzzoni has worked with prominent companies such as Eniricerche S.p.a. and Eniricerche S.p.a. Her innovative research has positioned her as a key figure in the biotechnology sector, contributing to advancements in vaccine technology.
Collaborations
Cuzzoni has collaborated with esteemed colleagues, including Guido Grandi and Francesca De Ferra. These partnerships have further enhanced her research and development efforts in the field.
Conclusion
Anna Cuzzoni's contributions to biotechnology through her innovative patents and collaborations highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in vaccine development and therapeutic solutions.